About Us
- Design and conduct clinical studies in breast and colorectal cancer to improve treatment and advance the standard of care.
- Learn about the heritage, expertise and vision that drives us forward every day.
  Learn More
- Meet the experts leading our organization in the pursuit of The Mission.
  Meet the Experts
- Read the latest announcements and press releases, or search our media library.
  Read the Latest
Our Network
- We leverage our expertise through close collaboration across our network to prove the efficacy of new cancer treatments.
- Thousands of sites facilitate trials by recruiting participants, administering treatments, and reporting results.
  View Sites
- Links to NCI National Clinical Trials Network along with Industry Partners and other Government Agencies.
  View Links
Patient Resources
Clinical Trials
Log In
- Visitors who have already been issued credentials must log in to access protected content.
  Log In
- Individuals working for sites that participate in NSABP clinical trials.
  Register Now
Support Our Mission

Clinical Trial Detailsnsabpwordpress2026-03-13T16:01:52-05:00

NSABP B-62 Ocular

Overview

Overview

NSABP B-62 Ocular

A Multicentre, Open-Label, Study Assessing Ophthalmic Safety of Camizestrant in ER+/HER2- Early Breast Cancer Patients Either Initiating Adjuvant Endocrine-Based Therapy (CAMBRIA-2) or Having Been Treated with Standard Adjuvant Endocrine-Based Therapy for At Least 2 Years (CAMBRIA-1).

Target Accrual: 160 patients

Status: Recruiting

ClinicialTrials.gov Identifier: NCT06767462

NSABP B-62 Ocular

Overview

Overview